Current position:Home >Product >
2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-
2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-(101618-68-2)
- Name: 2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-
- Synonyms:
- Molecular Formula:C32H39N3O3
- Molecular Weight:513.68
- CAS Registry Number:101618-68-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 101618-44-4/2,4-Pentadienamide, N-[2-[4-(2-aminobenzoyl)-1-piperazinyl]ethyl]-5-(3,4-dimethoxyphenyl)-, (E,E)-
- 101618-45-5/2-Propenamide, N-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethyl]-3-(4-hydroxy- 3,5-dimethoxyphenyl)-, (E)-
- 101618-47-7/Benzoic acid, 2-[[3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-, (E)-
- 101618-48-8/2-Propenamide, N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-3-(3,4,5-trimethoxyphenyl)-, (E)-
- 101618-49-9/2,4-Pentadienamide, N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-5-(4-hydroxy-3,5-dimethoxy phenyl)-, (E,E)-
- 101618-50-2/2,4-Pentadienamide, N-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethyl]-5-(4-hydroxy- 3,5-dimethoxyphenyl)-, (E,E)-
- 101618-52-4/Benzoic acid, 2-[[5-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2,4-pentadienyl]amino]-, (E,E)-
- 101618-54-6/2,4-Pentadienamide, N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-5-(3,4,5-trimethoxyphenyl)-, (E,E)-
- 101618-56-8/2,4-Pentadienamide, 5-(1,3-benzodioxol-5-yl)-N-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl]-, (E,E)-
- 101618-57-9/2,4-Pentadienamide, 5-(1,3-benzodioxol-5-yl)-N-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-, (E,E)-
- 101618-59-1/2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-
- 101618-60-4/2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[2-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo -7H-purin-7-yl)ethyl]-, (E)-
- 101618-61-5/Piperazine, 1-[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-4-[2-(diphenylmethoxy)eth yl]-, (E)-
- 101618-62-6/2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[2-(diphenylmethoxy)ethyl]-, (E)-
- 101618-63-7/2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(1,2,3,6-tetrahydro-1,3-dimethyl-2, 6-dioxo-7H-purin-7-yl)ethyl]-, (E)-
- 101618-64-8/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2- propenyl]-, (E)-
- 101618-65-9/Piperazine, 1-[3-(diphenylmethoxy)propyl]-4-[3-(4-hydroxy-3-methoxyphenyl)-1-oxo- 2-propenyl]-, (E)-
- 101618-66-0/2-Propenamide, N-[2-(diphenylmethoxy)ethyl]-3-(4-hydroxy-3-methoxyphenyl)-, (E)-
- 101618-67-1/2-Propenamide, N-[3-(diphenylmethoxy)propyl]-3-(4-hydroxy-3-methoxyphenyl)-, (E)-
- 101618-68-2/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E)-
- 101618-69-3/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[4-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-diox o-7H-purin-7-yl)butyl]-, (E)-
- 101618-71-7/2-Propenamide, 3-(3,4-dimethoxyphenyl)-N-[2-(diphenylmethoxy)ethyl]-, (E)-
- 101618-72-8/2-Propenamide, N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(4-hydroxy-3,5-dimethoxy phenyl)-, (E)-
- 101618-73-9/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[3-(4-hydroxy-3,5-dimethoxyphenyl)-1-ox o-2-propenyl]-, (E)-
- 101618-75-1/2-Propenamide, N-[2-(diphenylmethoxy)ethyl]-3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-
- 101618-76-2/2,4-Pentadienamide, 5-(3,4-dihydroxyphenyl)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-, (E,E)-
- 101618-79-5/2,4-Pentadienamide, N-[4-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]butyl]-5-(4-hydroxy- 3-methoxyphenyl)-, (E,E)-
- 101618-81-9/2,4-Pentadienamide, 5-(4-hydroxy-3-methoxyphenyl)-N-[2-(1,2,3,6-tetrahydro-1,3-dimethyl-2, 6-dioxo-7H-purin-7-yl)ethyl]-, (E,E)-
- 101618-82-0/Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-[5-(4-hydroxy-3-methoxyphenyl)-1-oxo-2, 4-pentadienyl]-, (E,E)-
- 101618-83-1/2,4-Pentadienamide, N-[2-(diphenylmethoxy)ethyl]-5-(4-hydroxy-3-methoxyphenyl)-, (E,E)-